Acusphere, Inc. to Host Conference Call to Discuss 2005 Q3 Results.WATERTOWN, Mass. -- Acusphere, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ACUS acus (a´kus) a needle or needle-like process. acus a needle or needle-like process. ) a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microparticle technology, today announced that it expects to release results for its third quarter of 2005 on Thursday, November 10, 2005, and hold a conference call on that date starting at 4:00 pm (EST EST electroshock therapy. EST abbr. electroshock therapy ) to discuss its financial results, its quarterly highlights and business outlook. To listen via live audio webcast, please visit the investor relations Investor relations The process by which the corporation communicates with its investors. section of the Company's website (www.acusphere.com) at least ten minutes prior to the start of the call and follow the directions there. The webcast will also be available as a replay, starting approximately one hour after the call is finished, through December 8th. Alternately, to access the call via live telephone, please dial 1-888-396-2356, using confirmation code 43579175. Internationally, the call may be accessed by dialing 1-617-847-8709, using the same confirmation code. In addition to the webcast replay, a telephone replay will be available from approximately 7:00 pm (EST) on November 10, 2005 through November 23, 2005. To access the replay please call 1-888-286-8010 and use the confirmation code of 67444207. Replay is also available internationally at 1-617-801-6888 using the same confirmation code, 67444207. Additionally, the Company indicated that it's previously announced presentation at the SG Cowen & Co. 6th Annual Global Health Care Conference on November 9th in Barcelona, Spain has been rescheduled to begin on that date at 5:25 pm local time. About Acusphere, Inc. Acusphere (NASDAQ: ACUS) is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology. Acusphere's three initial product candidates for which it has clinical data are designed to address unmet clinical needs within cardiology cardiology Medical specialty dealing with heart diseases and disorders. It began with the 1749 publication by Jean Baptiste de Sénac of contemporary knowledge of the heart. Diagnostic methods improved in the 19th century, and in 1905 the electrocardiograph was invented. , oncology and asthma. Acusphere's lead product candidate, AI-700, is a cardiovascular drug in Phase 3 clinical development. AI-700 is designed to enable ultrasound to compete more effectively with nuclear stress testing Determining the durability of a system by pushing it to its limits. Stress testing a network is performed by transmitting excessive numbers of packets or attempting to break in illegally. , the leading procedure for detecting coronary heart disease coronary heart disease: see coronary artery disease. coronary heart disease or ischemic heart disease Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis). . An estimated 10.7 million procedures are performed each year in the U.S. to detect coronary heart disease, the leading cause of death in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Acusphere's product candidates have been created using proprietary technology that enables Acusphere to control the porosity and size of nanoparticles and microparticles in a versatile manner that enables particles to be customized to address the delivery needs of a variety of drugs. For more information about Acusphere visit the Company's web site at www.acusphere.com. "Acusphere" is a trademark of Acusphere, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion